3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
38
Anemia, Refractory, with Excess of Blasts
31
Venous Thromboembolism
25
Myelodysplastic Syndromes
21
Neoplasms
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia
14
Anemia, Aplastic
14
Thrombocytopenia
10
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Leukemia, Myelomonocytic, Chronic
10
Myeloproliferative Disorders
9
Hematologic Neoplasms
9
Anemia
9
Venous Thrombosis
8
Primary Myelofibrosis
8
Multiple Myeloma
8
Hodgkin Disease
8
Febrile Neutropenia
8
Cytopenia
8
Pulmonary Embolism
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Congenital Bone Marrow Failure Syndromes
7
Anemia, Sickle Cell
7
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia, Biphenotypic, Acute
6
Fanconi Anemia
6
Bone Marrow Failure Disorders
6
Immunologic Deficiency Syndromes
5
Interventions
BIVV001
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Coagulation Protein Disorders
×
Classical hematology
×
Clear all
NCT06716814
2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3
Recruiting
104 enrolled